22 COVID-19 vaccines enter clinical trials in China: health official
Xinhua |
Updated: 2021-07-08 19:36
Share
Share - WeChat
BEIJING - Twenty-two COVID-19 vaccines have been approved to enter clinical trials in China, a health official said Thursday.
To date, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, said Yuan Lin, an official with the National Medical Products Administration (NMPA), at a press conference in Beijing.
By the end of June, the NMPA had granted emergency approval for clinical trials to 25 drugs intended for the treatment of COVID-19 and its indications, Yuan added.
- China launches construction of high-precision telescope project on 'roof of the world'
- South China city reports over 1,700 Chikungunya cases
- Xinjiang starts building new expressway linking north and south
- Intl tourists captivated by traditional opera gala in Kunshan
- Training and transport jets showed at Changchun air show
- Dunhuang expo offers a key platform for dialogue among civilizations
